The report "Spatial Genomics & Transcriptomics Market by Product (Instruments, Consumables, Services), Technique (Transcriptomics (IHC, ISH), Genomics (LCM), Service Type (Sample Prep, Sequencing), Application (Translation Research (Cancer)) - Global Forecast to 2029", is expected to reach USD 995.7 million in 2029 from USD 554.5 million in 2024, at a CAGR of 12.4% during the forecast period. Increasing adoption of spatial genomics and transcriptomics in drug discovery and development, and the introduction of novel products are driving the growth of the spatial genomics & transcriptomics market. Additionally, introducing technologically advanced instruments for spatial genomics analysis boosts the market growth.
Browse 613 market data Tables and 65 Figures spread through 451 Pages and in-depth TOC on "Spatial Genomics & Transcriptomics Market by Product (Instruments, Consumables, Services), Technique (Transcriptomics (IHC, ISH), Genomics (LCM), Service Type (Sample Prep, Sequencing), Application (Translation Research (Cancer)) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/spatial-genomics-transcriptomics-market-170900551.html
Consumables segment accounted for the largest share in 2023 in the spatial genomics and transcriptomics offerings market.
Based on product, the spatial genomics and transcriptomics market is segmented into consumables, instruments, and software. In 2023, the consumables segment accounted for the largest share of the product segment of spatial genomics and transcriptomics market. Market growth can largely be attributed to the growing applications of spatial genomics and transcriptomics in drug discovery & development and biomarker identification and the growing use of consumables. The spatial genomics and transcriptomics consumable market is growing mostly under the increasing demand for multi-omics consumables, especially those utilized in sample preparation. In both research and clinical environments, the growing acceptance of integrated multi-omics techniques calls for exact and high-quality sample preparation to produce consistent and significant results. Consumables supporting different omics analysis are therefore more in demand since they guarantee the integrity and correctness of the produced data.
In spatial genomics and transcriptomics application market, translational research segment accounted for the highest share in 2023.
Spatial genomics and transcriptomics market segmented in translational research, drug discovery and development by application. The translational research segment held the biggest proportion of the application segment in spatial genomics and transcriptomics market in 2023. Growing usage of spatial genomics and transcriptomics to ascertain high-throughput data on the organizational structure of cell content from tissue and cell species helps to explain most of the market expansion. Measuring all the gene activity in a tissue sample, spatial transcriptomics maps where its expression occurs. This benefit of spatial transcriptomics, together with the several uses of spatial genomics and transcriptomics studies, and the rising research grants and funding by government and non-governmental organizations, is projected to help to segment development.
North America was the biggest market for spatial genomics and transcriptomics in 2023.
Six main regions define the spatial genomics & transcriptomics market- North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. Though Europe in 2023 is ranked as the second biggest region for spatial genomics & transcriptomics, North America is the largest. Increased R&D investment, higher government funding, technological advancements, and new product launches account for the significant share in North America. Key players involved in this segment include lox Genomics (US), Bio-Rad Laboratories, Inc. (US), NanoString Technologies, Inc. (Bruker Spatial Biology, Inc.), Illumina, Inc. (US), and Standard BioTools (US).
Key players in the spatial genomics & transcriptomics market are NanoString Technologies, Inc. (Bruker Spatial Biology, Inc.) (US), 10x Genomics (US), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Bio-Techne (US), Standard BioTools (US), Akoya Biosciences, Inc. (US), Danaher Corporation (US), Macrogen, Inc. (South Korea), and Seven Bridges Genomics (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]